MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $18.72
0.37 (2.02%) Open Price: 18.27

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(06/03/26) $18.27
(06/04/26) $18.35
(06/04/26) (Qty.)439,951
(06/03/26) $17.69
(06/03/26) $18.61
(05/17/26) $15.76
(05/24/26) $19.60
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing